Molecular alterations in oral cancer using high-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue.
Cancer grade
Cancer pathology
Molecular medicine
Pressure cycling technology
Quantitative proteomics
Tumor differentiation
Journal
Journal of cell communication and signaling
ISSN: 1873-9601
Titre abrégé: J Cell Commun Signal
Pays: Netherlands
ID NLM: 101308338
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
27
01
2021
accepted:
01
02
2021
pubmed:
9
3
2021
medline:
9
3
2021
entrez:
8
3
2021
Statut:
ppublish
Résumé
Loss of cell differentiation is a hallmark for the progression of oral squamous cell carcinoma (OSCC). Archival Formalin-Fixed Paraffin-Embedded (FFPE) tissues constitute a valuable resource for studying the differentiation of OSCC and can offer valuable insights into the process of tumor progression. In the current study, we performed LC-MS/MS-based quantitative proteomics of FFPE specimens from pathologically-confirmed well-differentiated, moderately-differentiated, and poorly-differentiated OSCC cases. The data were analyzed in four technical replicates, resulting in the identification of 2376 proteins. Of these, 141 and 109 were differentially expressed in moderately-differentiated and poorly differentiated OSCC cases, respectively, compared to well-differentiated OSCC. The data revealed significant metabolic reprogramming with respect to lipid metabolism and glycolysis with proteins belonging to both these processes downregulated in moderately-differentiated OSCC when compared to well-differentiated OSCC. Signaling pathway analysis indicated the alteration of extracellular matrix organization, muscle contraction, and glucose metabolism pathways across tumor grades. The extracellular matrix organization pathway was upregulated in moderately-differentiated OSCC and downregulated in poorly differentiated OSCC, compared to well-differentiated OSCC. PADI4, an epigenetic enzyme transcriptional regulator, and its transcriptional target HIST1H1B were both found to be upregulated in moderately differentiated and poorly differentiated OSCC, indicating epigenetic events underlying tumor differentiation. In conclusion, the findings support the advantage of using high-resolution mass spectrometry-based FFPE archival blocks for clinical and translational research. The candidate signaling pathways identified in the study could be used to develop potential therapeutic targets for OSCC.
Identifiants
pubmed: 33683571
doi: 10.1007/s12079-021-00609-3
pii: 10.1007/s12079-021-00609-3
pmc: PMC8222490
doi:
Types de publication
Journal Article
Langues
eng
Pagination
447-459Références
Cancer Med. 2014 Apr;3(2):349-61
pubmed: 24515895
Int J Mol Sci. 2020 Feb 17;21(4):
pubmed: 32079300
Br J Cancer. 2019 Jun;120(12):1090-1098
pubmed: 31092908
Int J Mol Sci. 2020 Dec 29;22(1):
pubmed: 33383959
Cancer Sci. 2009 Sep;100(9):1605-11
pubmed: 19522851
Nat Med. 2011 Mar;17(3):320-9
pubmed: 21383745
Tumour Biol. 2014 Apr;35(4):2871-82
pubmed: 24338768
BMC Cancer. 2014 Sep 18;14:677
pubmed: 25234557
J Histochem Cytochem. 2010 Jun;58(6):517-27
pubmed: 20124091
Nat Commun. 2016 Jan 04;7:10259
pubmed: 26725330
Gene. 2016 Jan 15;576(1 Pt 3):385-94
pubmed: 26526134
PLoS Genet. 2014 Sep 11;10(9):e1004613
pubmed: 25211228
Int J Oncol. 2014 Apr;44(4):1376-84
pubmed: 24452447
Oncotarget. 2016 Aug 16;7(33):52631-52642
pubmed: 27437768
Nat Commun. 2018 Nov 14;9(1):4783
pubmed: 30429478
Mol Cell Proteomics. 2019 Sep;18(9):1796-1806
pubmed: 31253657
Oral Oncol. 2008 May;44(5):509-17
pubmed: 17826300
IUBMB Life. 2008 Dec;60(12):818-23
pubmed: 18949819
Nat Biotechnol. 2014 Mar;32(3):223-6
pubmed: 24727771
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13331-6
pubmed: 22853951
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Int J Mol Sci. 2018 Oct 04;19(10):
pubmed: 30287763
Nature. 2016 May 25;534(7605):55-62
pubmed: 27251275
Oncol Lett. 2020 Jan;19(1):93-102
pubmed: 31897119
J Cell Sci. 2002 Oct 15;115(Pt 20):3861-3
pubmed: 12244123
Mol Cell Proteomics. 2009 Aug;8(8):1988-98
pubmed: 19467989
Curr Opin Clin Nutr Metab Care. 2014 May;17(3):241-6
pubmed: 24535215
Acta Myol. 2007 Dec;26(3):136-44
pubmed: 18646562
Indian J Pathol Microbiol. 2019 Oct-Dec;62(4):529-536
pubmed: 31611435
Int J Cancer. 2003 Mar 10;104(1):28-35
pubmed: 12532416
J Oral Maxillofac Pathol. 2011 May;15(2):168-76
pubmed: 22529575
Nature. 2014 Mar 6;507(7490):104-8
pubmed: 24463520
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Int J Mol Sci. 2019 Aug 14;20(16):
pubmed: 31416244
Pathology. 2007 Jun;39(3):305-18
pubmed: 17558857
Int J Mol Sci. 2019 Apr 27;20(9):
pubmed: 31035605
N Engl J Med. 2001 Dec 27;345(26):1890-900
pubmed: 11756581
Mol Cell Endocrinol. 2016 Aug 15;431:123-32
pubmed: 27173027
Cell. 2016 Jul 28;166(3):755-765
pubmed: 27372738
J Exp Clin Cancer Res. 2019 Mar 6;38(1):115
pubmed: 30841909
Int J Cell Biol. 2012;2012:965618
pubmed: 22536252
Br J Cancer. 2020 Jan;122(1):4-22
pubmed: 31819192
Oncogene. 2007 Jan 4;26(1):65-76
pubmed: 16799640
Proteomics. 2003 Apr;3(4):413-21
pubmed: 12687609
PLoS One. 2010 Dec 08;5(12):e14253
pubmed: 21170380
FEBS J. 2013 May;280(10):2369-81
pubmed: 23438179
Cell Commun Signal. 2019 Nov 19;17(1):151
pubmed: 31744502
Lancet. 2008 May 17;371(9625):1695-709
pubmed: 18486742
Front Cell Dev Biol. 2020 Jul 03;8:522
pubmed: 32719793
Oral Oncol. 2020 Mar;102:104551
pubmed: 31986342
Immunol Invest. 2006;35(3-4):297-325
pubmed: 16916756
J Cell Biochem. 2018 Jun;119(6):4717-4728
pubmed: 29274284
Int J Exp Pathol. 2005 Aug;86(4):219-29
pubmed: 16045544
BMC Cancer. 2018 Oct 12;18(1):976
pubmed: 30314454
Biochim Biophys Acta. 2009 Sep;1794(9):1309-16
pubmed: 19595794
Oncotarget. 2017 Dec 4;9(1):1461-1482
pubmed: 29416706
J Proteome Res. 2010 Sep 3;9(9):4710-20
pubmed: 20604508
Science. 2004 Oct 8;306(5694):279-83
pubmed: 15345777
Nature. 2014 Sep 18;513(7518):382-7
pubmed: 25043054
J Proteome Res. 2005 Nov-Dec;4(6):2404-11
pubmed: 16335994
Cancers (Basel). 2020 Oct 28;12(11):
pubmed: 33126582
Clin Cancer Res. 2008 Feb 15;14(4):1002-14
pubmed: 18281532
J Appl Physiol (1985). 2020 Jun 1;128(6):1666-1676
pubmed: 32407241
J Cell Biol. 2012 Feb 20;196(4):395-406
pubmed: 22351925
Cell Syst. 2016 Mar 23;2(3):172-84
pubmed: 27135363
Am J Transl Res. 2017 Oct 15;9(10):4502-4511
pubmed: 29118912
J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):197-207
pubmed: 26401465
J Proteome Res. 2017 Apr 7;16(4):1632-1645
pubmed: 28241730
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Cancer Lett. 2006 Dec 8;244(2):143-63
pubmed: 16632194